Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.

Massimiliano Camilli, Marco Lombardi, Juan Guido Chiabrando, Marco Giuseppe Del Buono, Rocco Antonio Montone, Giuseppe Biondi-Zoccai, Filippo Crea, Giorgio Minotti

Journal: European heart journal. Cardiovascular pharmacotherapy 2023;7(4):e74-e76

PMID: 33930138

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, L.go Francesco Vito, 1. Rome, 00168, Italy.; Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Pres. Tte. Gral. Juan Domingo Perón. Buenos Aires, Argentina.; Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A.Gemelli. Rome, 00168, Italy.; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome. Latina, 04100, Italy.; Mediterranea-Cardiocentro, Via Ponte di Tappia. Napoli, 80133, Italy.; Department of Medicine, Center for Integrated Research and Unit of Drug Sciences, University Campus Bio-Medico, Via Alvaro Del Portillo 21, 00168 Rome, Italy.

DOI: 10.1093/ehjcvp/pvab034

Link outs

Free resources

Medical:

https://medlineplus.gov/heartfailure.html

Other Literature Sources:

https://scite.ai/reports/33930138

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Angiotensin Receptor Antagonists, Heart Failure, Neprilysin, Sodium-Glucose Transporter 2 Inhibitors